TF and myeloid sarcoma: In patients with MS, the levels of transferrin and ferritin in the CNS and the periphery differ with regard to multiple factors, such as the type/number of brain lesions, the disease course and severity, and administration of disease-modifying therapy, making the obtained results less coherent [36,37,38,39,40,41,42,43].